retatrutide phase 2 nejm 2023 weight loss percent 48 weeks 3: 60% Achieved Surgical-Level GLP-1 Medications for Weight Loss:

Stohs SJ, Hartman MJ

Cost considerations Because retatrutide is not commercially approved or available through ordinary prescribing, there is no legitimate standard retail cash price, insurance price, pharmacy price, or manufacturer savings-card pathway for retatrutide at this time

,

AAOPM, 2026) Check Your Coverage With GoalBMI Wellness Medicare GLP-1 Bridge Program Launched July 1, 2026 For the first time in history, Medicare beneficiaries can access weight loss medications through a federal program

Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y, Hirakata H, Iida M

Available exclusively at Melbourne Functional Medicine